Potential of human gammadelta T lymphocytes for immunotherapy of cancer.
about
What lessons can be learned from γδ T cell-based cancer immunotherapy trials?Immunotherapy for colorectal cancerRebalancing immune specificity and function in cancer by T-cell receptor gene therapy.Splenic gammadelta T cells regulated by CD4+ T cells are required to control chronic Plasmodium chabaudi malaria in the B-cell-deficient mouseImpact of diffusion barriers to small cytotoxic molecules on the efficacy of immunotherapy in breast cancer.Granulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease.Basic concepts of immune response and defense development.Anti-lymphoma effect of gammadelta T cells.Photoaffinity antigens for human gammadelta T cells.Adoptive Cell Therapy in Multiple Myeloma.Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity.Expression and function of PD-1 in human γδ T cells that recognize phosphoantigens.Specific requirements for Vgamma9Vdelta2 T cell stimulation by a natural adenylated phosphoantigen.Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.Adoptive transfer of aminobisphonate-expanded Vγ9Vδ2+ T cells does not control HIV replication in a humanized mouse model.The Generation of Human γδT Cell-Derived Induced Pluripotent Stem Cells from Whole Peripheral Blood Mononuclear Cell Culture.αβ-T-cell depleted donor lymphocyte infusion for leukemia relapse after allogeneic stem cell transplantation.Decreased number and reduced NKG2D expression of Vδ1 γδ T cells are involved in the impaired function of Vδ1 γδ T cells in the tissue of gastric cancer.Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment.Functional Plasticity of Gamma Delta T Cells and Breast Tumor Targets in Hypoxia.
P2860
Q26849323-722788B7-ECFD-4CF8-BE17-90B9A4A95684Q27021837-6DC1D36C-3309-4A11-9AD3-4FFED6C97ABFQ34084756-8C54C73C-CC92-47BC-96F2-4E63595AE593Q34601804-79BAF9A3-94E8-48D2-B8F4-664FB5C0F670Q34688777-5F9B2ADE-E04C-4502-A95C-FE356DF8272CQ35680360-937E30C9-C1DE-4D9F-AA35-E2C13363E0F6Q36161895-87D666A4-2EE4-49F7-B91A-0D44D1308F6FQ36194639-3DD1C41B-FADC-4450-8E1E-3D2693BC0F0EQ37226687-B88FA937-44A3-4601-B335-08ADE283C756Q38635138-6AC62F97-2848-4864-AD94-F3A55884E3A0Q38883322-32DC1811-0A49-422C-9349-C11D59BE2F64Q39602547-D1B209AC-E057-4F81-BDA6-46247DFFF41FQ39807695-BFF77E6C-49A8-465D-A284-CBBAB8CE30B0Q40106388-854123FB-11BD-4F8C-B3E7-506CD31DBD74Q40689871-D336301A-7F3A-4B46-8DB2-EC7EE102468CQ47160680-34EFC819-9D7E-4255-AB29-86271B0A9F4CQ50225357-0929DE5A-9404-4FA5-9898-3F191A074578Q53191662-87E6F1A6-F1E6-4768-A1B6-F657DF556F5EQ54540158-10E93FEC-BD0D-4B83-932E-2017F7E2FAC3Q55431748-28E3604C-AA5F-42F5-A6A8-BC1AB042F4D8
P2860
Potential of human gammadelta T lymphocytes for immunotherapy of cancer.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Potential of human gammadelta T lymphocytes for immunotherapy of cancer.
@ast
Potential of human gammadelta T lymphocytes for immunotherapy of cancer.
@en
type
label
Potential of human gammadelta T lymphocytes for immunotherapy of cancer.
@ast
Potential of human gammadelta T lymphocytes for immunotherapy of cancer.
@en
prefLabel
Potential of human gammadelta T lymphocytes for immunotherapy of cancer.
@ast
Potential of human gammadelta T lymphocytes for immunotherapy of cancer.
@en
P2093
P2860
P356
P1476
Potential of human gammadelta T lymphocytes for immunotherapy of cancer.
@en
P2093
Daniela Wesch
Dieter Kabelitz
Elke Pitters
Margot Zöller
P2860
P304
P356
10.1002/IJC.20445
P577
2004-12-01T00:00:00Z